Senores Pharmaceuticals schedules Q2 FY27 earnings call

Board & Shareholder Meetings View source PDF Explain this filing

SENORES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.2%Reaction day

₹1200.00

prior close

₹1210.80

announcement price

After-mkt

timing

Nifty Microcap 250market-2.3%+3.5% vs market

Pharmaceuticals peers, median of 170sector-1.6%+2.7% vs sector

On the reaction day the stock moved 3.5 pts more than Nifty Microcap 250 and 2.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.1

10m

-0.7

15m

-0.5

30m

-0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.2-2.3+3.5-1.6+2.7

Next day

+4.5-1.9+6.4-0.5+5.0

+9.1pendingpending+1.5+7.6

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Senores Pharmaceuticals will hold an earnings conference call on October 29, 2026 at 5:00 PM IST after announcing unaudited consolidated and standalone results for the quarter and half-year ended September 30, 2026. The call will feature the promoter and managing director, chairman, and chief financial officer. A recording and transcript will later be posted on the company website.

Likely market impact

The call may help investors assess Q2 and H1 FY27 performance, but this filing provides no new financial figures or business update.